Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | KCNA5 | P22460 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.40 |
| ▸ | KCNE1 | P15382 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL9065487 | 0.85 | CYP1A2 (0.42) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL30042788 | 0.82 | CYP3A4 (0.44) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL7335217 | 0.82 | CYP1A2 (0.44) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL4807002 | 0.82 | CYP1A2 (0.47) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL15668216 | 0.82 | CYP3A4 (0.44) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL11551880 | 0.81 | CYP1A2 (0.46) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL15550675 | 0.79 | CYP1A2 (0.41) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL2375133 | 0.74 | KDM4E (0.50) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL17603147 | 0.74 | — | — | |
| SCHEMBL243460 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1073428-B1 | DIHYDROXYPHENYL DERIVATIVES FOR HEPATOPROTECTION AND TREATMENT OF LIVER DISEASES | CHOONGWAE PHARMA CO LTD (KR) | 2004-10-27 | — | — | EP | claimed |
| EP-1073428-B1 | DIHYDROXYPHENYL DERIVATIVES FOR HEPATOPROTECTION AND TREATMENT OF LIVER DISEASES | CHOONGWAE PHARMA CO LTD (KR) | 2004-10-27 | — | — | EP | disclosed |
| US-6693126-B2 | OXIME-SUBSTITUTED M-DIHYDROXYBENZENE OR 1,3-BENZODIOXOLE COMPOUND OF GIVEN FORMULA AND AN INERT CARRIER | CHOONGWAE PHARM. CO., LTD. (KR) | 2004-02-17 | — | — | US | disclosed |
| US-20030083326-A1 | Dihydroxyphenyl derivatives for hepatoprotection and treatment of liver diseases | CHOONGWAE PHARM. CO., LTD. (KR) | 2003-05-01 | — | — | US | disclosed |
| EP-1073428-A1 | DIHYDROXYPHENYL DERIVATIVES FOR HEPATOPROTECTION AND TREATMENT OF LIVER DISEASES | Choongwae Pharma Co., Ltd. (KR) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999055318-A1 | DIHYDROXYPHENYL DERIVATIVES FOR HEPATOPROTECTION AND TREATMENT OF LIVER DISEASES | CHOONGWAE PHARM. CO., LTD. (KR) | 1999-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030083326-A1 | Dihydroxyphenyl derivatives for hepatoprotection and treatment of liver diseases | SLC10A1, SLC10A2, ABCB11 | CYP1A2 113/4885CYP3A4 287/4885SLC6A3 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.